Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3987899 | European Journal of Surgical Oncology (EJSO) | 2006 | 10 Pages |
Abstract
Pre-operative CMT enhances tumour response and could therefore, have a role in patients with possibly invaded resection margins or low lying cancers, although both acute toxicity and anorectal function are worse compared to RT alone. The final results of ongoing randomized trials will more accurately establish the role of pre-operative CMT in resectable rectal cancer patients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
W. Ceelen, P. Pattyn, T. Boterberg, M. Peeters,